Explore the details: https://bit.ly/4jq1eUD
Higher OCB counts in newly diagnosed MS were linked to broader MRI lesion spread and poorer verbal learning and memory.

Explore the details: https://bit.ly/4jq1eUD
Higher OCB counts in newly diagnosed MS were linked to broader MRI lesion spread and poorer verbal learning and memory.
Get the scoop: https://bit.ly/4dF2WxI
Thinning of a layer of nerve cells in the eye's retina was associated with slower cognitive processing in people with MS, per a study.
Take a closer look: https://bit.ly/4i0Zjn9
Like Bilbo Baggins, columnist Ben Hofmeister has "things to do," and says it is time to say farewell to his excellent and admirable readers.
Get the scoop: https://bit.ly/4yKBqHx
Briumvi may be more effective than Kesimpta or Ocrevus at preventing disability progression in relapsing MS, an indirect comparison shows.
Discover more: https://bit.ly/4hL90Hy
Reduced immune responses to the Epstein-Barr virus may help explain the efficacy of anti-CD20 therapy in people with MS, per a study.
Explore the details: https://bit.ly/4B6vRow
Parental stress may help explain the link between disease burden and lower self-esteem in children and adolescents with POMS.
Take a closer look: https://bit.ly/4jRxtMz
Columnist Ahna Crum steps into the role of caregiver and gains a different perspective on what it costs to care for someone else.
Take a closer look: https://bit.ly/3W1yAPW
A study found generic versions of certain MS treatments were linked to more variable disease biomarker profiles than brand-name drugs.
Explore the details: https://bit.ly/4elSxHq
A trial will test whether noninvasive nerve stimulation paired with hand rehab can improve function and support myelin repair in MS.
Get the scoop: https://bit.ly/4yJn4qY
Scientists have engineered a human "mini-brain" model that mimics MS damage and repair, offering a new way to test myelin-repairing therapies.
Discover more: https://bit.ly/3TtM9Hf
Quantum is working with Thermo Fisher to prepare a Phase 2 trial of Lucid-MS in progressive MS after FDA clearance.
Get the scoop: https://bit.ly/3TLgQrd
Columnist Desiree Lama looks forward to the change in seasons this autumn as a chance to listen to her body a little more closely.
Take a closer look: https://bit.ly/4yrR3Tz
A personalized neuropsychological rehab program may help people with MS manage cognitive issues, according to a feasibility study.
Get the scoop: https://bit.ly/4ycaYWn
Higher physical activity was linked to lower MS risk mainly among people with low sun exposure in a Swedish study.
Discover more: https://bit.ly/4hLFwb8
Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data from a small trial.
Get the scoop: https://bit.ly/4dp6NyQ
The National MS Society launched a 'Campaign to End MS,' aiming to raise $1 billion for research and to improve access to care and support.
Discover more: https://bit.ly/4zlggzP
A fast-track diagnostic pathway that includes a specific MRI marker helped cut the average time to diagnose MS by about half, per a review.
Get the scoop: https://bit.ly/4jAlJxU
A study tied altered neurovascular coupling, which matches brain activity with blood flow, to poorer cognitive function in MS.
Take a closer look: https://bit.ly/4iZNzUa
The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved for two MS types.
Get the scoop: https://bit.ly/4yqdlpj
An estimated 3.1 million people worldwide are now living with MS, up from about 2.8 million in 2020 and 1.8 million in 2013, a report shows.